No article text was recorded for this version.
drug repurposing
Version 1 of 195 papers107 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Explainable drug repurposing via path based knowledge graph completion
- Blog: Repurposing bunamidine hydrochloride as a potent antimicrobial agent targeting vancomycin-resistant <i>Enterococcus</i> membranes
- Blog: Computational drug repositioning of atorvastatin for ulcerative colitis
- Blog: The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
- Blog: Identification and Exploration of Novel Macrophage M2-Related Biomarkers and Potential Therapeutic Agents in Endometriosis
- Blog: The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
- Blog: A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma
- Blog: Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learning
- Blog: Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
- Blog: Antivirals against the Chikungunya Virus
- Blog: Mouse model phenotypes provide information about human drug targets
- Blog: Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations
- Blog: Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing
- Blog: Prediction of Drug Indications Based on Chemical Interactions and Chemical Similarities
- Blog: MD-Miner: a network-based approach for personalized drug repositioning
- Blog: EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
- Blog: SInCRe - structural interactome computational resource for Mycobacterium tuberculosis
- Blog: Fenofibrate Increases Radiosensitivity in Head and Neck Squamous Cell Carcinoma via Inducing G2/M Arrest and Apoptosis
- Blog: 'RE: fine drugs': an interactive dashboard to access drug repurposing opportunities
- Blog: The Mu.Ta.Lig. Chemotheca: A Community-Populated Molecular Database for Multi-Target Ligands Identification and Compound-Repurposing
- Blog: Foundational Model-aided Automatic High-throughput Drug Screening Using Self-controlled Cohort Study
- Blog: Network-Based Inference Methods for Drug Repositioning
- Blog: Chemical and Textual Embeddings for Drug Repurposing
- Blog: Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
- Blog: The Impact of Computational Drug Discovery on Society
- Blog: Compound Screening with Deep Learning for Neglected Diseases: Leishmaniasis
- Blog: Reflections on: Finding Melanoma Drugs Through a Probabilistic Knowledge Graph
- Blog: The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19
- Blog: Repurposing Niclosamide to Modulate Renal RNA-Binding Protein HuR for the Treatment of Diabetic Nephropathy in db/db Mice
- Blog: Hyperbolic Molecular Representation Learning for Drug Repositioning
- Blog: G Protein-Coupled Receptor 40 Agonist LY2922470 Alleviates Ischemic-Stroke-Induced Acute Brain Injury and Functional Alterations in Mice
- Blog: Mass Enhanced Node Embeddings for Drug Repurposing
- Blog: Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19
- Blog: Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)
- Blog: L-Type Ca2+ Channel Inhibition Rescues the LPS-Induced Neuroinflammatory Response and Impairments in Spatial Memory and Dendritic Spine Formation
- Blog: Representation learning of drug and disease terms for drug repositioning
- Blog: Discovery, Biological Evaluation and Binding Mode Investigation of Novel Butyrylcholinesterase Inhibitors Through Hybrid Virtual Screening
- Blog: Concept of the Munich/Augsburg Consortium Precision in Mental Health for the German Center of Mental Health
- Blog: Drug repurposing for COVID-19 via knowledge graph completion
- Blog: Uncovering new drug properties in target-based drug-drug similarity networks
- Blog: DeepDRA: Drug repurposing using multi-omics data integration with autoencoders
- Blog: Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma
- Blog: A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase
- Blog: Boosting Drug-Disease Association Prediction for Drug Repositioning via Dual-Feature Extraction and Cross-Dual-Domain Decoding
- Blog: Drug Repurposing for Cancer: An NLP Approach to Identify Low-Cost Therapies
- Blog: In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
- Blog: Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
- Blog: Disulfiram Protects Against Radiation-Induced Intestinal Injury in Mice
- Blog: Machine learning of big data in gaining insight into successful treatment of hypertension
- Blog: <i>In silico</i> and <i>in vitro</i> drug screening identifies new therapeutic approaches for Ewing sarcoma
- Blog: Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer’s Disease
- Blog: Berberine is a novel mitochondrial calcium uniporter (MCU) inhibitor that disrupts MCU-EMRE assembly
- Blog: Integration of Neighbor Topologies Based on Meta-Paths and Node Attributes for Predicting Drug-Related Diseases
- Blog: Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
- Blog: Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity
- Blog: Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
- Blog: Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
- Blog: Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice
- Blog: Mining on Alzheimer’s diseases related knowledge graph to identity potential AD-related semantic triples for drug repurposing
- Blog: Periadventitial Application of Rapamycin-Loaded Nanoparticles Produces Sustained Inhibition of Vascular Restenosis
Showing 60 of 95 papers.
History & citation
Current · Permanent link
- Multi-Modal Knowledge Integration for Computational Drug Repositioning merged into this direction (58% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_drug_repurposing_6b8bb92e,
title = {drug repurposing},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-repurposing/rdr_6b8bb92e8019449e8155a04cbe303f06},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_drug_repurposing_6b8bb92e_v1,
title = {drug repurposing},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-repurposing/rdr_6b8bb92e8019449e8155a04cbe303f06/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}